Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 2 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Harmony Biosciences Holdings Inc have a median target of 52.00, with a high estimate of 59.00 and a low estimate of 28.00. The median estimate represents a 56.49% increase from the last price of 33.23.
High | 77.6% | 59.00 |
Med | 56.5% | 52.00 |
Low | -15.7% | 28.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | +61.29% |
Average growth rate | +186.66% |
More ▼
Revenue history & estimates in USD
Average growth rate | +4.08% |
Average growth rate | +55.83% |
More ▼